CRP and inflammatory bowel disease: Although stool calprotectin and CRP were elevated during relapse compared to those in stable remission, the difference was statistically significant only for CRP within the total IBD cohort (2.8 (0.3–20.4) vs. 1.3 (0.3–32.4) pg/ml, P<0.02).